Losartan does not slow down the progression of more advanced Alzheimer’s, study finds
New research led by the University of Bristol, has shown the drug losartan, normally used to treat hypertension, is not effective in slowing down the progression of Alzheimer’s…
Blood thinners may prevent cognitive decline in older patients with atrial fibrillation
The anticoagulant medication dabigatran yielded similar results to warfarin for the prevention of cognitive decline in older adults with atrial fibrillation after two years of treatment, according to…
Adults with acute heart failure benefit when treated with a type 2 diabetes medication
Adults treated with empagliflozin during hospitalization for acute heart failure experienced a clinical benefit such as increased survival, lower risk of heart failure hospital readmission and an overall…
Oral PCSK9 inhibitor found to be safe, effective to lower cholesterol, in first human trial
Results from two early clinical studies show the first version of an oral PCSK9-inhibitor cholesterol-lowering medicine was well tolerated and highly effective at reducing high levels of LDL…
Long-term, low-dose aspirin did not affect risk of dementia in adults with type 2 diabetes
Taking daily low-dose aspirin for seven years did not affect the risk of dementia or mental decline among adults with type 2 diabetes, according to late-breaking research presented…